胃癌免疫治疗研究进展  

Advances in immunotherapy of gastric cancer

作　　者：张晨[1] 苏文[2] Zhang Chen;Su Wen(The Second Clinical Medical College of Shanxi Medical University,Taiyuan 030001,China;Department of Immunology,Shanxi Provincial Cancer Hospital,Affiliated Cancer Hospital of Shanxi Medical University,Taiyuan 030013,China)

机构地区：[1]山西医科大学第二临床医学院,太原030001 [2]山西医科大学附属肿瘤医院山西省肿瘤医院免疫室,太原030013

出　　处：《肿瘤研究与临床》2021年第7期481-484,共4页Cancer Research and Clinic

基　　金：山西省科技攻关计划(201903D321027)。

摘　　要：胃癌是来源于胃黏膜上皮细胞的消化道常见肿瘤,病理类型以腺癌居多,其治疗方案是根据分期和病理类型决定的。目前胃癌的治疗方式包括通过胃镜或外科手术切除肿瘤、化疗和放疗等。尽管胃癌的治疗策略取得了进展,但治疗效果仍不理想。免疫治疗具有精准作用于肿瘤微环境和应答持久的特点,已经成为包括胃癌在内的各种肿瘤的治疗方法。Gastric cancer is a common digestive tract tumor derived from the gastric mucosal epithelial cells.Adenocarcinoma is the most common pathological type of gastric cancer,and its treatment is determined by the stage and pathological type.The current treatments of gastric cancer include endoscopic or surgical resection of tumor,chemotherapy and radiotherapy,etc.Although the treatment strategies of gastric cancer have made progress,the efficacy is still not ideal.Immunotherapy has the characteristics of precise effect on tumor microenvironment and long-lasting response,and it has become an important treatment method for various tumors,including gastric cancer.

关 键 词：胃肿瘤 免疫疗法 癌症疫苗 免疫疗法 过继 免疫检查点抑制剂 

分 类 号：R735.2[医药卫生—肿瘤]